Investing Profile

Chris Garabedian

InvestorVC
CEO, Xontogeny and Portfolio Manager, PXV Fund
perceptivelife.com/team/Boston, Massachusetts
Photo of Chris Garabedian, Investor at Perceptive Advisors
Your Intro Paths to Chris Garabedian
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Chris Garabedian on

cb
Current Investing Position
Perceptive Advisors Investor
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
21

Chris Garabedian is on these Sector & Stage Rankings

Chris Garabedian's Investments On Record (15)

CompanyStageDateRound SizeTotal Raised
Zucara Therapeutics
Series BNov 2024$20M
Series AMar 2020$21M
$41M
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Maha Katabi (Sofinnova Investments), Aaron Royston (venBio), Charles Homcy (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures)
CereVasc
Series BMay 2024$70M
Series AJun 2020$44M
$110M
Delve Bio
Series AJun 2023$35M
$35M
Peroxitech Therapeutics
Series ADec 2022$25M
SeedMay 2021
$25M
Tellus Therapeutics
Series ADec 2022$35M
SeedMay 2021$2M
$37M
PolyCore Therapeutics
SeedApr 2022
$500K
VivoSense
Series AMar 2022$25M
$25M